openPR Logo
Press release

Migraine Drugs Market Increasing Demand, Growth Analysis and Future Outlook by 2030

04-02-2024 02:06 PM CET | Health & Medicine

Press release from: Orion Market Research

Migraine Drugs Market Increasing Demand, Growth Analysis

The global migraine drugs market is projected to grow at a CAGR of over 9% during the forecast period. The global migraine drugs industry has several players operating in the market and providing products for the treatment of migraine globally. Some of the prominent players operating in the global migraine drugs market are Allergan Plc, Amgen Inc., Novartis International AG, Eli Lilly & Co., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc. Pfizer Inc., and Teva Pharmaceuticals Inc. among others. These players are significantly contributing to the global migraine drugs market and have a major share during the forecast period.

A full report of Global Migraine Drugs Market is available at: https://www.omrglobal.com/industry-reports/migraine-drugs-market

Some of the strategies that are majorly being adopted by these players include new products offering, expansion, partnership & collaboration, and mergers & acquisitions among others. For instance, Allergan's Ubrogepant and Eli Lilly's Lasmiditan are the migraine drugs based on the advanced mechanism of action.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/migraine-drugs-market

In February 2020, Biohaven Pharmaceutical Holding Co. Ltd.'s oral pill known as Nurtec ODT, chemically known as rimegepant was approved by the US FDA. This drug is consumed for dismissing the pain after the onset of migraine headaches. The dug falls under CGRP and directly competes with the first approved Allergan Plc's Ubrelvy.

In December 2019, the migraine drug Ubrogepant (Ubrelvy) manufactured by Allergen Plc has been approved by the US FDA. Ubrogepant is the CGRP drug in tablet form which is meant to be taken immediately after the onset of migraines by adults.

In September 2018, Ajovy, a migraine drug manufactured by Teva Pharmaceutical Industries Ltd. received US regulatory approval. Ajovy is an injectable drug that is to be taken in a few months for relieving migraines in adults.

In May 2018, Aimovig, the drug manufactured by Amgen Inc. received the US FDA approval. The drug is given monthly by self-injection and charges up to $575 monthly in the US. The company manufactured Aimovig in partnership with Novartis International AG, a Swiss multinational pharmaceutical company.

Current Market Trends Covered in the Global Migraine Drug Market Report:

• Increased healthcare spending and improving healthcare infrastructure is influencing the global migraine drugs industry growth during the forecast period.
• Shifting consumer preferences towards the use of injections for a quicker relief is expected to provide ample growth opportunities for market growth.
• The injection segment will account for significant growth in the market.
• The novel drug innovations, various regulatory approvals, and geographical expansions will be the key strategy of the players.
• North America region is expected to hold a prominent share in the migraine drugs market.

Global Migraine Drugs Market - Segmentation

By Type

• Acute Migraine Treatment
• Preventive Migraine Treatment

By Route of Administration

• Oral
• Injectable
• Others (Spray)

Global Migraine Drugs Market - Segmentation by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• Allergan Plc
• Amgen Inc.
• Astrazeneca PLC
• Bausch Health Companies Inc.
• Biohaven Pharmaceutical Holding Co. Ltd.
• Reddy's Laboratories Ltd.
• Eli Lilly & Co.
• GlaxoSmithKline Plc
• Lundbeck A/S
• Johnson & Johnson Services Inc.
• Merck & Co. Inc.

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Visit more report at

https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/

https://www.linkedin.com/pulse/aesthetic-threads-market-increasing-demand-growth-2031-vishwakarma-pyg5f

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Migraine Drugs Market Increasing Demand, Growth Analysis and Future Outlook by 2030 here

News-ID: 3449374 • Views:

More Releases from Orion Market Research

Wearable AI Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Wearable AI Market Size, Trends, Latest Insights, Analysis and Forecast 2024-203 …
The global wearable AI market is anticipated to grow at a CAGR of 29.8% during the forecast period. Fitness trackers, demonstrated by brands like Fitbit, employ AI to monitor and analyze physical activity, heart rate, and sleep patterns. They also provide personalized fitness recommendations. These wearable devices can even detect potential health issues and send alerts to users or healthcare professionals. Additionally, smartwatches with AI integration offer voice-activated assistance, answer
Quantum Computing Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Quantum Computing Market Size, Trends, Latest Insights, Analysis and Forecast 20 …
Global quantum computing market is anticipated to grow at a considerable CAGR of 30.6% during the forecast period. Governments and companies around the world are investing heavily in quantum computing research and development. This is helping to accelerate the development of quantum computers and related technologies. Quantum computers are expected to be much faster than traditional computers for certain types of tasks. This could lead to breakthroughs in fields such
Military Cloud Computing Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Military Cloud Computing Market Size, Trends, Latest Insights, Analysis and Fore …
The global military cloud computing market is anticipated to grow at a considerable CAGR of 12.2% during the forecast period. Governments around the world are promoting the adoption of cloud computing in the military sector for several reasons, some of which are described next. Cloud computing can help military organizations reduce their IT costs by eliminating the need to invest in and maintain their data centers. This can free up
Generative AI Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
Generative AI Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2 …
Global generative AI market is anticipated to grow at a considerable CAGR of 48.5% during the forecast period. Generative AI algorithms need large datasets of training data to learn. The increasing availability of data from the internet, social media, and other sources is making it possible to train more powerful and sophisticated generative AI algorithms. The increasing availability of data is making it easier to develop and deploy generative AI

All 5 Releases


More Releases for Migraine

Digital Migraine Treatment Market: Size & Trends Shows a Rapid Growth by 2030- C …
A report was released recently that sheds lots of light on the Digital Migraine Treatment Industry. The report covers an overview of the Market along with a detailed explanation that provides a lot of insight. The report also analyzes the production as well as management technology in various end-user industries. An in-depth study in some new and prominent industry trends, analysis of the competition and regional analysis that is very
Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025
Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea and even altered vision in some cases. The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs. Get Access to TOC /
Migraine Therapeutics Pipeline Analysis -Results, Designation, Collaboration
Migraine is a type of a severe headache that is characterized by the intense throbbing in one area of the head. According to National Institute of Neurological Disorders and Stroke, migraine is three times common in women than in men and it is heralded by visual disturbances such as zig-zag lines vision and flashing lights. Access Report Overview: https://www.psmarketresearch.com/market-analysis/migraine-therapeutics-pipeline-analysis People having migraine generally have frequent attacks that cause, anxiety, stress,
Migraine KOL Interview
ReportsWorldwide has announced the addition of a new report title Migraine KOL Interview to its growing collection of premium market research reports. For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/biosimilar-insulin-market-access February 08, 2017 We interviewed a neurologist based in the US who specializes in headache medicine to gauge his current and anticipated future use of acute and prophylactic agents in the treatment of episodic
Migraine Disease Coverage Forecast and Market Analysis
ReportsWorldwide has announced the addition of a new report title Migraine Disease Coverage Forecast and Market Analysis to its growing collection of premium market research reports. For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/migraine-disease-coverage-forecast-and-market-analysis Introduction Migraine is a common, disabling, and recurring neurological disorder characterized by severe headache co-occurring with nausea, vomiting, and other symptoms, the duration of which can range from hours to days.
Global Anti-migraine Drugs Market to be Driven by Increasing Awareness Regarding …
A new market research study by Transparency Market Research provides a detailed analysis of the global market for anti-migraine drugs, including the major growth factors, barriers, product segmentation, current trends, major geographical segments, and competitive landscape. The research report, titled “Anti-Migraine Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” also presents the historical statistics and forecast figures to the readers, with the help